Altimmune, Inc. (ALT)
NASDAQ · Healthcare
Altimmune, Inc. annual/quarterly long term debt history from 2016 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Altimmune, Inc. long term debt for the quarter ending December 31, 2025 were 34.3M, a 648.46% increase year-over-year.
- Altimmune, Inc. long term debt for 2025 were 34.3M, a 648.46% increase from 2022.
- Altimmune, Inc. long term debt for 2022 were 4.6M, a 215.06% increase from 2021.
- Altimmune, Inc. long term debt for 2021 were 1.5M, a 20.48% decrease from 2020.
- Altimmune, Inc. long term debt for 2020 were 1.8M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Altimmune, Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $34 |
| 2022 | $5 |
| 2021 | $1 |
| 2020 | $2 |
| 2019 | $2 |
| 2018 | $1 |
| 2017 | $1 |
| 2016 | $1 |
| Altimmune, Inc. Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2025-12-31 | $34 |
| 2022-12-31 | $5 |
| 2021-12-31 | $1 |
| 2020-12-31 | $2 |
| 2019-12-31 | $2 |
| 2018-12-31 | $1 |
| 2017-12-31 | $1 |
| 2016-12-31 | $1 |
Altimmune, Inc. Long Term Debt — FAQ
Altimmune, Inc. (ALT) long term debt over the last 12 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ALT's long term debt history?
The chart and table above show Altimmune, Inc.'s long term debt by year and by quarter, including the growth rate.